{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:13:59Z","timestamp":1793412839875,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T00:00:00Z","timestamp":1440633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Multiple system atrophy trust UK","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"name":"Cortico Basal Degeneration (CBD) Solutions, Reta Lila Weston Institute of Neurological Studies","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"name":"Government of Kuwait","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"name":"Parkinson's UK (GB), National Institute of Health Research","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","award":["8047"],"award-info":[{"award-number":["8047"]}],"id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0700943"],"award-info":[{"award-number":["G0700943"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","award":["F1002"],"award-info":[{"award-number":["F1002"]}],"id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010933\/1"],"award-info":[{"award-number":["MR\/L010933\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson's UK (GB), Multiple system atrophy trust UK (GB) and Progressive Supranuclear Palsy (Europe) association","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"name":"Wellcome trust\/MRC","award":["WT089698"],"award-info":[{"award-number":["WT089698"]}]},{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","award":["J1101"],"award-info":[{"award-number":["J1101"]}],"id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1100643"],"award-info":[{"award-number":["G1100643"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cortico Basal Degeneration Solutions","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"name":"Medical Research Council (GB), Dystonia Medical research foundation, Parkinson's Disease Foundation","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]},{"name":"Parkinson's UK (GB), Cortico Basal Degeneration Solutions, Reta Lila Weston Institute for Neurological Studies","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13024-015-0038-3","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T22:51:21Z","timestamp":1440543081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-6631","authenticated-orcid":false,"given":"Aoife P.","family":"Kiely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine T.","family":"Asi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Proukakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw R.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Limousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"issue":"1","key":"38_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of [alpha]-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14(1):38\u201348.","journal-title":"Nat Rev Neurosci"},{"key":"38_CR2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"M Polymeropoulos","year":"1997","unstructured":"Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"issue":"2","key":"38_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of \u03b1-synuclein causes parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164\u201373.","journal-title":"Ann Neurol"},{"key":"38_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet. 1998;18:106\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"38_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2012","unstructured":"Proukakis C, Dudzik CG, Breier T, MacKay DS, Cooper JM, Millhauser GL, et al. A novel alpha-synuclein missense mutation in Parkinson\u2019s disease. Neurology. 2012;80(11):1062\u20134.","journal-title":"Neurology"},{"issue":"5","key":"38_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi Y, Kara E, Limousin P, Ling H, Lewis P, et al. \u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol. 2013;125(5):753\u201369.","journal-title":"Acta Neuropathol"},{"key":"38_CR7","doi-asserted-by":"crossref","unstructured":"Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, et al. A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging. 2014.","DOI":"10.1016\/j.neurobiolaging.2014.03.024"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2013.04.058","volume":"546","author":"E Kara","year":"2013","unstructured":"Kara E, Lewis PA, Ling H, Proukakis C, Houlden H, Hardy J. \u03b1-Synuclein mutations cluster around a putative protein loop. Neurosci Lett. 2013;546:67\u201370.","journal-title":"Neurosci Lett"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1212115","volume":"369","author":"TM-SAR Collaboration","year":"2013","unstructured":"Collaboration TM-SAR. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013;369:233\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"38_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honor\u00e9 A, Rozas N, et al. G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome. Ann Neurol. 2013;73(4):459\u201371.","journal-title":"Ann Neurol"},{"issue":"2","key":"38_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.parkreldis.2013.11.008","volume":"20","author":"T Tokutake","year":"2014","unstructured":"Tokutake T, Ishikawa A, Yoshimura N, Miyashita A, Kuwano R, Nishizawa M, et al. Clinical and neuroimaging features of patient with early-onset Parkinson\u2019s disease with dementia carrying SNCA p.G51D mutation. Parkinsonism Relat Disord. 2014;20(2):262\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"38_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamaneurol.2014.994","volume":"71","author":"E Kara","year":"2014","unstructured":"Kara E, Kiely AP, Proukakis C, Giffin N, Love S, Hehir J, et al. A 6.4 mb duplication of the \u03b1-synuclein locus causing frontotemporal dementia and parkinsonism: phenotype-genotype correlations. JAMA Neurol. 2014;71(9):1162\u201371.","journal-title":"JAMA Neurol"},{"issue":"2","key":"38_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bpa.12168","volume":"25","author":"K Seidel","year":"2014","unstructured":"Seidel K, Mahlke J, Siswanto S, Kr\u00fcger R, Heinsen H, Auburger G, et al. The brainstem pathologies of Parkinson\u2019s disease and dementia with lewy bodies. Brain Pathol. 2014;25(2):121\u201335.","journal-title":"Brain Pathol"},{"issue":"1","key":"38_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"G Kovacs","year":"2012","unstructured":"Kovacs G, Wagner U, Dumont B, Pikkarainen M, Osman A, Streichenberger N, et al. An antibody with high reactivity for disease-associated \u03b1-synuclein reveals extensive brain pathology. Acta Neuropathol. 2012;124(1):37\u201350.","journal-title":"Acta Neuropathol"},{"key":"38_CR15","doi-asserted-by":"crossref","unstructured":"Kovacs GG, Breydo L, Green R, Kis V, Puska G, L\u0151rincz P, et al. Intracellular processing of disease-associated \u03b1-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis. 2014.","DOI":"10.1016\/j.nbd.2014.05.020"},{"issue":"11","key":"38_CR16","first-page":"3257","volume":"119","author":"L Chen","year":"2009","unstructured":"Chen L, Periquet M, Wang X, Negro A, McLean PJ, Hyman BT, et al. Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest. 2009;119(11):3257\u201365.","journal-title":"J Clin Invest"},{"issue":"11","key":"38_CR17","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1021\/ja210866j","volume":"134","author":"M Hejjaoui","year":"2012","unstructured":"Hejjaoui M, Butterfield S, Fauvet B, Vercruysse F, Cui J, Dikiy I, et al. Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: \u03b1-synuclein phosphorylation at tyrosine 125. J Am Chem Soc. 2012;134(11):5196\u2013210.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"38_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1096\/fj.01-0517fje","volume":"16","author":"A Negro","year":"2002","unstructured":"Negro A, Brunati AM, Donella-Deana A, Massimino ML, Pinna LA. Multiple phosphorylation of \u03b1-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J. 2002;16(2):210\u20132.","journal-title":"FASEB J"},{"issue":"11","key":"38_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nrn2499","volume":"9","author":"H-C Tai","year":"2008","unstructured":"Tai H-C, Schuman EM. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci. 2008;9(11):826\u201338.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"38_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","volume":"131","author":"M Komatsu","year":"2007","unstructured":"Komatsu M, Waguri S, Koike M, Sou Y-S, Ueno T, Hara T, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131(6):1149\u201363.","journal-title":"Cell"},{"issue":"5","key":"38_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaneurol.2013.172","volume":"70","author":"KM Doherty","year":"2013","unstructured":"Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, et al. Parkin disease: a clinicopathologic entity? JAMA Neurol. 2013;70(5):571\u20139.","journal-title":"JAMA Neurol"},{"issue":"7","key":"38_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.25887","volume":"29","author":"YT Asi","year":"2014","unstructured":"Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL. Neuropathological features of multiple system atrophy with cognitive impairment. Mov Disord. 2014;29(7):884\u20138.","journal-title":"Mov Disord"},{"issue":"6","key":"38_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/mds.25499","volume":"28","author":"M Kasten","year":"2013","unstructured":"Kasten M, Klein C. The many faces of alpha-synuclein mutations. Mov Disord. 2013;28(6):697\u2013701. doi: 10.1002\/mds.25499 . Epub 2013 May 14.","journal-title":"Mov Disord"},{"issue":"12","key":"38_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","volume":"68","author":"J Fuchs","year":"2007","unstructured":"Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson E-M, Sch\u00fcle B, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology. 2007;68(12):916\u201322.","journal-title":"Neurology"},{"issue":"12","key":"38_CR25","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/mds.22682","volume":"24","author":"K Nishioka","year":"2009","unstructured":"Nishioka K, Ross OA, Ishii K, Kachergus JM, Ishiwata K, Kitagawa M, et al. Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord. 2009;24(12):1811\u20139.","journal-title":"Mov Disord"},{"issue":"6","key":"38_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord. 2013;28(6):811\u20133.","journal-title":"Mov Disord"},{"issue":"2","key":"38_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0022-510X(02)00006-0","volume":"195","author":"W Marui","year":"2002","unstructured":"Marui W, Iseki E, Nakai T, Miura S, Kato M, U\u00e9da K, et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci. 2002;195(2):153\u20139.","journal-title":"J Neurol Sci"},{"key":"38_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"38_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, Xie S, Hurtig H, Duda J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007;114(3):221\u20139.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"38_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2990.2010.01136.x","volume":"37","author":"F Geser","year":"2011","unstructured":"Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, et al. TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol Appl Neurobiol. 2011;37(4):358\u201365. Epub 2010\/10\/15.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"38_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I, Choi-Lundberg D, Ho W-H, Castillo PE, et al. Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25(1):239\u201352.","journal-title":"Neuron"},{"issue":"3","key":"38_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0959-437X(00)00082-4","volume":"10","author":"HA Rohan de Silva","year":"2000","unstructured":"Rohan de Silva HA, Khan NL, Wood NW. The genetics of Parkinson\u2019s disease. Curr Opin Genet Dev. 2000;10(3):292\u20138.","journal-title":"Curr Opin Genet Dev"},{"issue":"23","key":"38_CR33","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","volume":"286","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein \u03b1-synuclein. J Biol Chem. 2011;286(23):20710\u201326.","journal-title":"J Biol Chem"},{"issue":"3","key":"38_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fern\u00e1ndez-Chac\u00f3n R, Schl\u00fcter OM, S\u00fcdhof TC. \u03b1-synuclein cooperates with CSP\u03b1 in preventing neurodegeneration. Cell. 2005;123(3):383\u201396.","journal-title":"Cell"},{"key":"38_CR35","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"J Anderson","year":"2006","unstructured":"Anderson J, Walker D, Goldstein J, de Laat R, Banducci K, Caccavello R, et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006;281:29739\u201352.","journal-title":"J Biol Chem"},{"issue":"5493","key":"38_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"BI Giasson","year":"2000","unstructured":"Giasson BI, Duda JE, Murray IVJ, Chen Q, Souza JM, Hurtig HI, et al. Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions. Science. 2000;290(5493):985\u20139.","journal-title":"Science"},{"issue":"45","key":"38_CR37","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG. Ubiquitination of \u03b1-synuclein in lewy bodies is a pathological event Not associated with impairment of proteasome function. J Biol Chem. 2003;278(45):44405\u201311.","journal-title":"J Biol Chem"},{"issue":"2","key":"38_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12035-012-8328-z","volume":"47","author":"E Guerrero","year":"2013","unstructured":"Guerrero E, Vasudevaraju P, Hegde M, Britton GB, Rao KS. Recent advances in \u03b1-synuclein functions, advanced glycation, and toxicity: implications for Parkinson\u2019s disease. Mol Neurobiol. 2013;47(2):525\u201336.","journal-title":"Mol Neurobiol"},{"key":"38_CR39","doi-asserted-by":"crossref","unstructured":"Yamashita S, Sakashita N, Yamashita T, Tawara N, Tasaki M, Kawakami K, et al. Concomitant accumulation of \u03b1-synuclein and TDP-43 in a patient with corticobasal degeneration. J Neurol. 2014;1\u20139.","DOI":"10.1007\/s00415-014-7491-8"},{"issue":"4","key":"38_CR40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW. Colocalization of Tau and alpha-synuclein epitopes in lewy bodies. J Neuropathol Exp Neurol. 2003;62(4):389\u201397.","journal-title":"J Neuropathol Exp Neurol"},{"key":"38_CR41","doi-asserted-by":"crossref","unstructured":"Sengupta U, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL, Lasagna-Reeves CA, Gerson JE, Paulucci-Holthauzen AA, et al. Pathological interface between oligomeric alpha-synuclein and Tau in synucleinopathies. Biol Psychiatry. 2015.","DOI":"10.1016\/j.biopsych.2014.12.019"},{"key":"38_CR42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-2001-3608","volume":"3","author":"S Hossain","year":"2001","unstructured":"Hossain S, Alim A, Takeda K, Kaji H, Shinoda T, Ueda K. Limited proteolysis of NACP\/alpha-synuclein. J Alzheimers Dis. 2001;3:577\u201384.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"38_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004302","volume":"10","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro S, Reim\u00e3o-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D, et al. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson\u2019s disease. PLoS Genet. 2014;10(5), e1004302.","journal-title":"PLoS Genet"},{"issue":"2\u20133","key":"38_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000355516","volume":"13","author":"D Selkoe","year":"2014","unstructured":"Selkoe D, Dettmer U, Luth E, Kim N, Newman A, Bartels T. Defining the native state of \u03b1-synuclein. Neurodegener Dis. 2014;13(2\u20133):114\u20137.","journal-title":"Neurodegener Dis"},{"issue":"7362","key":"38_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477(7362):107\u201310. Epub 2011\/08\/16.","journal-title":"Nature"},{"issue":"9","key":"38_CR46","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1074\/jbc.M112.403311","volume":"288","author":"U Dettmer","year":"2013","unstructured":"Dettmer U, Newman AJ, Luth ES, Bartels T, Selkoe D. In vivo cross-linking reveals principally oligomeric forms of \u03b1-synuclein and \u03b2-synuclein in neurons and Non-neural cells. J Biol Chem. 2013;288(9):6371\u201385.","journal-title":"J Biol Chem"},{"issue":"7453","key":"38_CR47","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/nature12125","volume":"498","author":"J Burre","year":"2013","unstructured":"Burre J, Vivona S, Diao J, Sharma M, Brunger AT, Sudhof TC. Properties of native brain [agr]-synuclein. Nature. 2013;498(7453):E4\u20136.","journal-title":"Nature"},{"key":"38_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnmol.2014.00063","volume":"7","author":"G Atkin","year":"2014","unstructured":"Atkin G, Paulson H. Ubiquitin pathways in neurodegenerative disease. Front Mol Neurosci. 2014;7:63. doi: 10.3389\/fnmol.2014.00063 . eCollection 2014.","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"38_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1289\/ehp.1003013","volume":"119","author":"HM Gao","year":"2011","unstructured":"Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS. Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease. Environ Health Perspect. 2011;119(6):807\u201314. Epub 2011\/01\/20.","journal-title":"Environ Health Perspect"},{"issue":"10","key":"38_CR50","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li J-Y, Holton JL, Lindvall O, Revesz T. Research in motion: the enigma of Parkinson\u2019s disease pathology spread. Nat Rev Neurosci. 2008;9(10):741\u20135.","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"38_CR51","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1074\/jbc.M411638200","volume":"280","author":"EA Greenbaum","year":"2005","unstructured":"Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, et al. The E46K mutation in \u03b1-synuclein increases amyloid fibril formation. J Biol Chem. 2005;280(9):7800\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"38_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","volume":"576","author":"W Choi","year":"2004","unstructured":"Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, Anthony Crowther R, et al. Mutation E46K increases phospholipid binding and assembly into filaments of human \u03b1-synuclein. FEBS Lett. 2004;576(3):363\u20138.","journal-title":"FEBS Lett"},{"issue":"11","key":"38_CR53","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4(11):1318\u201320. Epub 1998\/11\/11.","journal-title":"Nat Med"},{"issue":"2","key":"38_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT. Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci. 2000;97(2):571\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"38_CR55","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","volume":"274","author":"L Narhi","year":"1999","unstructured":"Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, et al. Both familial Parkinson\u2019s disease mutations accelerate \u03b1-synuclein aggregation. J Biol Chem. 1999;274(14):9843\u20136.","journal-title":"J Biol Chem"},{"issue":"17","key":"38_CR56","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","volume":"23","author":"M-B Fares","year":"2014","unstructured":"Fares M-B, Bouziad NA, Dikiy I, Mbefo MK, Jovi\u010di\u0107 A, Kiely A, et al. The novel Parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells. Hum Mol Genet. 2014;23(17):4491\u2013509.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"38_CR57","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/jnc.12806","volume":"131","author":"NJ Rutherford","year":"2014","unstructured":"Rutherford NJ, Moore BD, Golde TE, Giasson BI. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of \u03b1-synuclein. J Neurochem. 2014;131(6):859\u201367.","journal-title":"J Neurochem"},{"issue":"41","key":"38_CR58","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1021\/bi5010365","volume":"53","author":"D Ghosh","year":"2014","unstructured":"Ghosh D, Sahay S, Ranjan P, Salot S, Mohite GM, Singh PK, et al. The newly discovered Parkinson\u2019s disease associated Finnish mutation (A53E) attenuates \u03b1-synuclein aggregation and membrane binding. Biochemistry (Mosc). 2014;53(41):6419\u201321.","journal-title":"Biochemistry (Mosc)"},{"issue":"22","key":"38_CR59","doi-asserted-by":"publisher","first-page":"15474","DOI":"10.1074\/jbc.M113.544049","volume":"289","author":"Y-C Chi","year":"2014","unstructured":"Chi Y-C, Armstrong GS, Jones DNM, Eisenmesser EZ, Liu C-W. Residue histidine 50 plays a Key role in protecting \u03b1-synuclein from aggregation at physiological pH. J Biol Chem. 2014;289(22):15474\u201381.","journal-title":"J Biol Chem"},{"issue":"32","key":"38_CR60","doi-asserted-by":"publisher","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","volume":"289","author":"O Khalaf","year":"2014","unstructured":"Khalaf O, Fauvet B, Oueslati A, Dikiy I, Mahul-Mellier A-L, Ruggeri FS, et al. The H50Q mutation enhances \u03b1-synuclein aggregation, secretion, and toxicity. J Biol Chem. 2014;289(32):21856\u201376.","journal-title":"J Biol Chem"},{"issue":"4","key":"38_CR61","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1074\/jbc.M114.610527","volume":"290","author":"R Porcari","year":"2015","unstructured":"Porcari R, Proukakis C, Waudby CA, Bolognesi B, Mangione PP, Paton JFS, et al. The H50Q mutation induces a 10-fold decrease in the solubility of \u03b1-synuclein. J Biol Chem. 2015;290(4):2395\u2013404.","journal-title":"J Biol Chem"},{"issue":"10","key":"38_CR62","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, et al. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc Natl Acad Sci. 2011;108(10):4194\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"38_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.23746","volume":"73","author":"LV Kalia","year":"2013","unstructured":"Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE. \u03b1-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol. 2013;73(2):155\u201369.","journal-title":"Ann Neurol"},{"issue":"1","key":"38_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","volume":"116","author":"K Markopoulou","year":"2008","unstructured":"Markopoulou K, Dickson D, McComb R, Wszolek Z, Katechalidou L, Avery L, et al. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson\u2019s disease. Acta Neuropathol. 2008;116(1):25\u201335.","journal-title":"Acta Neuropathol"},{"issue":"14","key":"38_CR65","doi-asserted-by":"publisher","first-page":"11526","DOI":"10.1074\/jbc.M111.306902","volume":"287","author":"LR Lemkau","year":"2012","unstructured":"Lemkau LR, Comellas G, Kloepper KD, Woods WS, George JM, Rienstra CM. Mutant protein A30P \u03b1-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. J Biol Chem. 2012;287(14):11526\u201332.","journal-title":"J Biol Chem"},{"issue":"5","key":"38_CR66","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.21966","volume":"67","author":"K Seidel","year":"2010","unstructured":"Seidel K, Sch\u00f6ls L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, et al. First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol. 2010;67(5):684\u20139.","journal-title":"Ann Neurol"},{"issue":"3","key":"38_CR67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1212\/01.wnl.0000299387.59159.db","volume":"70","author":"T Obi","year":"2008","unstructured":"Obi T, Nishioka K, Ross OA, Terada T, Yamazaki K, Sugiura A, et al. Clincopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology. 2008;70(3):238\u201341.","journal-title":"Neurology"},{"issue":"4","key":"38_CR68","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/archneur.65.4.514","volume":"65","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan CF, et al. Patients homozygous and heterozygous for snca duplication in a family with parkinsonism and dementia. Arch Neurol. 2008;65(4):514\u20139.","journal-title":"Arch Neurol"},{"issue":"6","key":"38_CR69","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s004010051177","volume":"99","author":"K Gwinn-Hardy","year":"2000","unstructured":"Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, et al. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol. 2000;99(6):663\u201372. Epub 2000\/06\/27.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"38_CR70","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004;127(12):2657\u201371.","journal-title":"Brain"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-015-0038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-015-0038-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-015-0038-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-015-0038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T18:57:08Z","timestamp":1718045828000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-015-0038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1186\/s13024-015-0038-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]},"assertion":[{"value":"22 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}